Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference
VANCOUVER, British Columbia--(BUSINESS WIRE)--Jun 19, 2023--
Source: eagletribune.com
📰 Abuse Liability News
Abuse Liability News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abuse Liability. Real-time updates on events, politics, business and more.
Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference
Wellbeing Digital Sciences Inc. , an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and... | June 20, 2023
City Of United Kingdom United States Natalie Dolphin Najla Guthrie Subsidiary Of Wellbeing Digital Sciences
Source: marketscreener.com
Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference
VANCOUVER, British Columbia--(BUSINESS WIRE)--Jun 19, 2023--
Source: joplinglobe.com
Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference
VANCOUVER, British Columbia--(BUSINESS WIRE)--Jun 19, 2023--
Source: valdostadailytimes.com
Vallon Pharmaceuticals Announces Topline Results of its Pivotal SEAL Study for Lead Program, ADAIR, for the Treatment of ADHD
– Study did not meet primary endpoint of significant reduction in Emax Drug Liking for ADAIR vs reference dextroamphetamine, although a trend in favor of ADAIR was observed –... | March 21, 2022
United States Jenene Thomas David Baker Exchange Commission Drug Administration Vallon Pharmaceuticals Inc
Source: marketscreener.com
Vallon Pharmaceuticals Reports Fiscal Year 2021 Financial Results and Provides Business Update
-Topline dataforpivotalabusestudy oftheCompany’s leadinvestigationalprogram ADAIRexpected this quarter
United States Jenene Thomas David Baker Exchange Commission Vallon Pharmaceuticals Inc University Of Kentucky
Source: kulr8.com
Vallon Pharmaceuticals Announces Achievement of Last
- Topline results from pivotal SEAL study expected in Q1 2022 - If approved, ADAIR will target the growing Adderall® segment of the ~$9 billion U.S....
United States David Baker Vallon Pharmaceuticals Inc Abuse Liability Amphetamine Sulfate Immediate Release Formulation Drug Liking
Source: globenewswire.com
FinancialNewsMedia.com: Ongoing R&D Leading to Discovery of More Efficient Therapies for Acute Myeloid Leukemia Therapeutics
PALM BEACH, Fla., Dec. 15, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs)
United States Adamr Craig Stephenv Faraone Kostenloser Wertpapierhandel Jeffrey Newcorn Thomas Heineman
Source: finanznachrichten.de
Ongoing R&D Leading to Discovery of More Efficient Therapies for Acute Myeloid Leukemia Therapeutics
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Acute Myeloid Leukemia (AML) is a type of blood cancer which usually affects white blood cells (WBCs),...
Source: prnewswire.com
Relmada Therapeutics to Present Data at the 60th Annual Meeting of the American College of Neuropsychopharmacology
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS),...
Puerto Rico Jack Henningfield Tim Mccarthy Clinical Research Program Relmada Therapeutics Inc Therapeutics Inc
Source: prnewswire.com